A new CSP position was established today on Teva Pharmaceutical Industries Ltd (TEVA). All prices include IB commissions.
| Criteria | Value |
|---|
| Dividend Champions Status | Contender |
| Years of Consecutive Dividend Increases | 12 |
| Fair Value Estimate | $63.00 |
| Target Buy Price | $45.00 |
| Target Margin of Safety | 28.57% |
| Actual Buy Price | $45.00 |
| Actual Margin of Safety | 28.57% |
| Date | Stock | Description | Transaction | Status | Stock Investment | Income Generated |
|---|
| 5/23/2011 | TEVA | CSP Margin Used | CSP 100 TEVA @ 45.00 | | ($4,500.00) | |
| 5/23/2011 | TEVA | Initial Put Option | STO 1 Sep11 45.00 Put @ 1.23 | | | $122.98 |
Position Summary
| Cost Basis | ($4,500.00) |
| Income Generated | $122.98 |
| Percent Income Generated | 2.73% |
| Annualized Income Generated | 8.60% |
| Net Profit If Assigned | $122.98 |
| Percent Return If Assigned | 2.73% |
| Annualized Return If Assigned | 8.60% |
| Days Held to Expiration | 116 days |
